Dietary arachidonic acid supplementation increases thromboxane synthesizing activity in platelets from diabetics (original) (raw)

Increased biosynthesis of thromboxane A2by diabetic platelets

William Lucky

European Journal of Clinical Investigation, 1979

View PDFchevron_right

Increased arachidonic acid uptake by platelets from insulin-dependent diabetics and diabetic rats

Jose Enrique

Diabetes Research and Clinical Practice, 1989

View PDFchevron_right

Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes

Gerard Mauco

Biochimica et biophysica acta, 1985

View PDFchevron_right

Arachidonic acid metabolism in platelets and endothelial cells

Babette Weksler

Progress in Lipid Research, 1981

View PDFchevron_right

The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis

Bianca Rocca

Cardiovascular Research, 2021

View PDFchevron_right

Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production

jean-louis sebedio

The Journal of Lipid Research

View PDFchevron_right

Diabetic Patients Without Vascular Complications Display Enhanced Basal Platelet Activation and Decreased Antioxidant Status

Michel Lagarde

Diabetes, 2004

View PDFchevron_right

Arachidonic Acid Metabolism in Endothelial Cells and Platelets

Nazmul Islam

Annals of The New York Academy of Sciences, 1982

View PDFchevron_right

Oxidative pathways of arachidonic acid as targets for regulation of platelet activation

Andrés Trostchansky

Prostaglandins & Other Lipid Mediators, 2019

View PDFchevron_right

Diacylglycerol lipase pathway is a minor source of released arachidonic acid in thrombin-stimulated human platelets

Bruce Holub

Biochemical and Biophysical Research Communications, 1986

View PDFchevron_right

Platelet thromboxane synthesizing activity in non-insulin-dependent diabetes: Correlation with diabetic retinopathy and diabetic treatment

Masataka Shiraki

Prostaglandins, Leukotrienes and Medicine, 1985

View PDFchevron_right

Arachidonic acid metabolism in platelets of patients with essential thrombocythaemia

Jesus Santamaria Cesar

Thrombosis Research, 1995

View PDFchevron_right

Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation

Gundu Rao

American Journal of Hematology, 1985

View PDFchevron_right

Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets

Valentina Shpakova

Thrombosis Research, 2018

View PDFchevron_right

Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors

Chiara cerletti

Biochemical Pharmacology, 1986

View PDFchevron_right

Dietary n-9, n-6 and n-3 fatty acids modify linoleic acid more than arachidonic acid levels in plasma and platelet lipids and minimally affect platelet thromboxane formation in the rabbit

Susanna Colli

The Journal of Nutritional Biochemistry, 1990

View PDFchevron_right

Inhibitory effect of stearidonic acid (18∶4 n−3) on platelet aggregation and arachidonate oxygenation

Michel Lagarde

Lipids, 1989

View PDFchevron_right

Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients

Michel Lagarde

Thrombosis and haemostasis, 2015

View PDFchevron_right

Anandamide activates human platelets through a pathway independent of the arachidonate cascade

Domenico Del Principe

FEBS Letters, 1999

View PDFchevron_right

Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2

Bernardo Vargaftig

Prostaglandins, 1977

View PDFchevron_right

Evidence for the generation of hydroxyl radical during arachidonic acid metabolism by human platelets

Daljeet Singh

American Journal of Hematology, 1981

View PDFchevron_right

Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B is increased in type IIA hypercholesterolemic subjects

Fulvio Magni

Atherosclerosis, 1986

View PDFchevron_right

Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects

Donatella Caruso

Atherosclerosis, 1986

View PDFchevron_right

The metabolism of arachidonic acid by platelets in nephrotic syndrome

Arrigo Schieppati

Kidney International, 1984

View PDFchevron_right

Metabolism of icosa-5,11,14-trienoic acid in human platelets and the inhibition of arachidonic acid metabolism in human platelets by icosa-5,8,14-triynoic and icosa-5,11,14-triynoic acids

Rhobert Evans

Prostaglandins, 1985

View PDFchevron_right

Synthesis of all- trans arachidonic acid and its effect on rabbit platelet aggregation

Abdelouahid Samadi

Bioorganic & Medicinal Chemistry Letters, 2005

View PDFchevron_right

In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation

Michel Lagarde

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985

View PDFchevron_right

Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients

Ian Puddey

Atherosclerosis, 2003

View PDFchevron_right

Effects of bioactive‐rich extracts of pomegranate, persimmon, nettle, dill, kale and Sideritis and isolated bioactives on arachidonic acid induced markers of platelet activation and aggregation

Nevena Kardum

Journal of the Science of Food and Agriculture, 2013

View PDFchevron_right

EC PHARMACOLOGY AND TOXICOLOGY Review Article Arachidonic Acid and Platelet-Activating Factor as Central Players in the Metabolic Syndrome. Lessons from the Use of the Ginkgo Biloba Extract

George Kudolo

View PDFchevron_right